A drug approved to treat certain autoimmune diseases and cancers successfully alleviated symptoms of a rare genetic syndrome called autoimmune polyendocrine syndrome type 1 (APS-1). Researchers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback